Range Low Price High Price Comment
30 days $2.92 $6.86 Wednesday, 27th Mar 2024 CASI stock ended at $3.00. During the day the stock fluctuated 6.95% from a day low at $2.97 to a day high of $3.18.
90 days $2.92 $8.19
52 weeks $1.86 $8.48

Historical CASI Pharmaceuticals prices

Date Open High Low Close Volume
2023-05-04 $2.92 $2.92 $2.70 $2.88 5 524
2023-05-03 $2.64 $2.80 $2.64 $2.72 11 110
2023-05-02 $2.72 $2.81 $2.60 $2.65 24 487
2023-05-01 $2.71 $2.78 $2.69 $2.69 24 648
2023-04-28 $2.89 $2.90 $2.81 $2.86 3 993
2023-04-27 $2.84 $3.06 $2.82 $2.95 8 398
2023-04-26 $3.02 $3.22 $2.84 $2.84 6 587
2023-04-25 $3.04 $3.04 $2.97 $2.97 22 796
2023-04-24 $2.99 $3.09 $2.86 $3.04 10 737
2023-04-21 $2.98 $3.14 $2.98 $3.01 11 364
2023-04-20 $3.00 $3.07 $3.00 $3.03 4 099
2023-04-19 $3.15 $3.15 $3.02 $3.09 8 437
2023-04-18 $3.23 $3.25 $3.02 $3.21 14 281
2023-04-17 $3.59 $3.59 $3.26 $3.30 33 136
2023-04-14 $3.00 $3.66 $2.88 $3.59 92 410
2023-04-13 $2.78 $3.09 $2.74 $2.94 41 980
2023-04-12 $2.88 $2.88 $2.64 $2.77 23 177
2023-04-11 $3.16 $3.16 $2.51 $2.80 75 275
2023-04-10 $3.65 $3.65 $3.12 $3.17 82 148
2023-04-06 $3.62 $3.70 $3.35 $3.70 110 692
2023-04-05 $3.14 $3.70 $3.10 $3.40 101 148
2023-04-04 $2.66 $3.21 $2.66 $3.15 182 198
2023-04-03 $2.40 $2.79 $2.25 $2.64 73 092
2023-03-31 $2.02 $2.35 $1.95 $2.32 30 352
2023-03-30 $1.95 $2.10 $1.91 $2.07 38 836
Click to get the best stock tips daily for free!

About CASI Pharmaceuticals

CASI Pharmaceuticals CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT